beta-Blocker use following myocardial infarction: low prevalence of evidence-based dosing.

@article{Goldberger2010betaBlockerUF,
  title={beta-Blocker use following myocardial infarction: low prevalence of evidence-based dosing.},
  author={Jeffrey J. Goldberger and Robert Ogden Bonow and Michael S Cuffe and Alan Dyer and Yves D Rosenberg and Robert A O'rourke and Prediman Krishan Shah and Sidney C. Smith},
  journal={American heart journal},
  year={2010},
  volume={160 3},
  pages={435-442.e1}
}
BACKGROUND Quality improvement programs have shown increased use of beta-blockers post-myocardial infarction (MI), but there are no data on whether appropriate doses are administered. METHODS In a prospective registry that enrolled consecutive patients with MI, we evaluated beta-blocker dosing at discharge after MI and 3 weeks later and assessed clinical predictors for treatment with very low doses. We studied 1,971 patients (70.8% male) with a mean age of 63.9 +/- 13.7 years, of whom 48.2… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 10 extracted citations

Similar Papers

Loading similar papers…